Investigating the Safety of Fampridine in Patients with Different Stages of Multiple Sclerosis
Background: Fampridine is the only drug approved by the US Food and Drug Administration (FDA) for people with multiple sclerosis (MS) to improve their movement and has exhibited a clinically significant improvement in gait function in a subset of MS patients with Expanded Disability Status Scale (ES...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-01-01
|
| Series: | International Journal of Preventive Medicine |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/ijpvm.ijpvm_292_23 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|